HR-6342 : Still Just a Bill


SBIC Capital Infusion Act of 2020

This bill provides economic assistance to small businesses affected by COVID-19 (i.e., coronavirus disease 2019), and it reestablishes the New Markets Venture Capital Program.

Specifically, the bill provides additional leverage for small business investment companies (SBICs) by requiring the Small Business Administration (SBA), when calculating the maximum amount of outstanding leverage made available to SBICs, to exclude a certain amount of outstanding leverage to small businesses affected by COVID-19. Any excluded amounts must be used solely for working capital purposes.

The bill also reestablishes the New Markets Venture Capital Program, through which the SBA, in partnership with investment companies, encourages developmental venture capital investment in small businesses located in low-income areas.

Action Timeline

Action DateTypeTextSource
2020-03-23IntroReferralReferred to the House Committee on Small Business.House floor actions
2020-03-23IntroReferralIntroduced in HouseLibrary of Congress

Sponsor :

Sharice Davids [D] (KS-3)
See Cosponsors

Policy Area :

Commerce
Related Subjects
  • Business investment and capital
  • Cardiovascular and respiratory health
  • Emergency medical services and trauma care
  • Infectious and parasitic diseases
  • Small business
Related Geographic Entities
Related Organizations

Related Bills

See Related Bills